Barnes Kelly Ann 4

What Happened
Kelly Ann Barnes, a director of Fractyl Health, received a compensatory grant of options covering 22,500 shares on 2026-06-10. The grant is reported at an acquisition price of $0 (derivative security) on the Form 4; this is an award under the company’s non-employee director compensation policy rather than an open‑market purchase or sale.

Key Details

• Transaction date: 2026-06-10; Form 4 filed 2026-06-11 (timely filing).
• Transaction type/code: Award/Grant (A) of derivative securities (stock options).
• Shares/options granted: 22,500; reported acquisition price: $0.00.
• Vesting: Single installment vested on the earlier of the next annual meeting of stockholders or the first anniversary of the grant, contingent on continued service. (See footnote describing the director compensation policy.)
• Shares owned after transaction: not specified in the filing.
• No indication of exercise, sale, tax withholding, 10b5-1 plan, or late filing.

Context
This was a compensatory option grant to a non-employee director — it does not represent an immediate purchase of stock or a sale. Options only translate to market exposure if and when they vest and are exercised; such grants are routine director compensation and should be viewed as a retention/compensation item rather than a direct trading signal.